Role of oxidative-nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure. - Wikidata - awgldk - TriplyDB

Role of oxidative-nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure.

Role of oxidative-nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure.

http://www.wikidata.org/entity/Q55663138

about

Nitric oxide and peroxynitrite in health and disease Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential The cGMP signaling pathway as a therapeutic target in heart failure with preserved ejection fraction Is physical activity able to modify oxidative damage in cardiovascular aging?The electrophile responsive proteome: integrating proteomics and lipidomics with cellular function Differential effects of late-life initiation of low-dose enalapril and losartan on diastolic function in senescent Fischer 344 x Brown Norway male rats.Conundrum of pathogenesis of diabetic cardiomyopathy: role of vascular endothelial dysfunction, reactive oxygen species, and mitochondria.Xanthine oxidase inhibitor allopurinol attenuates the development of diabetic cardiomyopathy.NF-kappaB-induced oxidative stress contributes to mitochondrial and cardiac dysfunction in type II diabetes.Antiapoptotic effects of Phe140Asn, a novel human granulocyte colony-stimulating factor mutant in H9c2 rat cardiomyocytes Is reversal of endothelial dysfunction still an attractive target in modern cardiology?Improvement of aging-associated cardiovascular dysfunction by the orally administered copper(II)-aspirinate complex Diminished antioxidant activity of high-density lipoprotein-associated proteins in systolic heart failure Reduced acute vascular injury and atherosclerosis in hyperlipidemic mice transgenic for lysozyme.Metabolic alterations induce oxidative stress in diabetic and failing hearts: different pathways, same outcome.Molecular Mechanisms of Retinoid Receptors in Diabetes-Induced Cardiac Remodeling.Mitochondria-derived superoxide and voltage-gated sodium channels in baroreceptor neurons from chronic heart-failure rats Novel insights into interactions between mitochondria and xanthine oxidase in acute cardiac volume overload.Catalpol inhibits apoptosis in hydrogen peroxide-induced cardiac myocytes through a mitochondrial-dependent caspase pathway.Levosimendan inhibits release of reactive oxygen species in polymorphonuclear leukocytes in vitro and in patients with acute heart failure and septic shock: a prospective observational study Role of poly(ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complications: endothelial dysfunction, as a common underlying theme.Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors Vascular dysfunction in aging: potential effects of resveratrol, an anti-inflammatory phytoestrogen.Beneficial effects of a novel ultrapotent poly(ADP-ribose) polymerase inhibitor in murine models of heart failure.Macro- and micronutrients in patients with congestive heart failure, particularly African-Americans.Congestive heart failure and Alzheimer's disease.S-nitrosylation: NO-related redox signaling to protect against oxidative stress.Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease.Guava leaves polyphenolics-rich extract inhibits vital enzymes implicated in gout and hypertension in vitro Phospholipid-mediated signaling systems as novel targets for treatment of heart disease.Inflammation and endothelial dysfunction during aging: role of NF-kappaB Xanthine oxidoreductase in respiratory and cardiovascular disorders.CB1 cannabinoid receptor inhibition: promising approach for heart failure?Single dose treatment with PARP-inhibitor INO-1001 improves aging-associated cardiac and vascular dysfunction.Acute heart failure: patient characteristics and pathophysiology.Timing and duration of interventions in clinical trials for patients with hospitalized heart failure.Oxidative stress and accelerated vascular aging: implications for cigarette smoking.Biochemical and cellular toxicology of peroxynitrite: implications in cell death and autoimmune phenomenon.

P2860

Q24645400-3BD78284-BD95-4057-B52D-B4F31170E0FB Q24652967-FFE9961C-40BF-47F6-B8D3-31D84616C8B6 Q24656131-37A6AF69-91F1-47B9-B4AD-A051D20A4DC4 Q27024279-18A60E3B-9EA0-4231-B3DC-BB1732C8AAC8 Q27025850-8F18F48F-7005-4EE7-9D41-CC6372F477CA Q28388959-DE45E3B5-1D8C-45C2-9CD5-785B46DA6DCF Q30451313-F34DE6AE-C4D6-45A9-B974-1D9977AC9F8B Q33357265-8B3CC117-9AAE-432F-A300-0DDDBAA0F286 Q33643575-E57162DB-2959-43FF-ADE8-EB00ED93843B Q33814830-97B0A87E-1594-4EF1-9AEA-FAB91FC3A91F Q34049210-A9A4CBAC-4221-4A73-9D74-E604A6855F2C Q34179077-9093F7EC-340A-482B-ABA5-1B534BD1FD0D Q34307113-9B5CF0FB-236F-43A6-B8EE-5A9EE55440A4 Q34504604-AFD08C6C-21A3-4236-9017-796E3D4E7480 Q35221896-20279AAB-AAD3-4054-9086-01979387D696 Q35667039-423DD528-3B1D-4612-B790-8E59C46CF04B Q35667311-0DCF802B-C14F-4CBE-B32E-3A6C36762F54 Q35951204-F76D7D33-DDC0-4D86-8635-23CBF1ACC432 Q35998409-1370AD88-5EA1-48F6-A82D-593EEFD5FD14 Q36013981-6A623015-D428-4B58-9F6E-C2E70C9CEA59 Q36070389-BE115000-49D4-4BD4-9EE3-704E6F72E7B5 Q36342643-807AC981-A41E-4149-B78C-665AC340B316 Q36416372-BBC45CC8-6663-4E73-BF1A-402263254DD1 Q36426742-CFC55CCF-663F-4752-ADC0-95E1EFEA257C Q36431841-FC7B420D-3F21-4C8A-B4F9-3967E4225F87 Q36464461-70DB8F60-5BDB-48AE-9F8F-79C87BF42D9C Q36536216-4059D257-D640-49C7-BC20-0EEF1EB84004 Q36582766-06515934-1438-4564-8389-252DEF83556B Q36598832-4FD75429-669A-416F-BA74-13C97346EF33 Q36734840-DBB454FF-60DE-475C-81EB-AEDCB8786682 Q36810873-B3A4A78E-5DA5-4D9E-8CF9-2593FA95A207 Q36814743-1B918E22-2E09-4718-87C4-5131D340E315 Q36956379-A7881557-5FE6-4761-B59A-C4608428CB74 Q37111434-CB21F619-EB50-4FF9-9690-8C3231CD5A02 Q37160279-C02D4E59-CF5B-4A2C-96BA-687CF7A74552 Q37198120-9FA80538-7A30-4D47-9F76-B38845302BFF Q37297364-00D0D75A-0A53-4A1D-8745-B4D8BE03AD85 Q37354429-37366EA6-2A8B-451C-8D8C-5D6A717299F0 Q37373701-A7BA430D-1C12-4FB8-B485-50B2A2C87BF6 Q37530895-7FF31B61-6875-40C5-B641-4F5FCB0B1E9B

P2860

Role of oxidative-nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure.

http://www.wikidata.org/entity/Q55663138

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Role of oxidative-nitrosative ...... diomyopathy and heart failure.

@en

Role of oxidative-nitrosative ...... diomyopathy and heart failure.

@nl

type

label

Role of oxidative-nitrosative ...... diomyopathy and heart failure.

@en

Role of oxidative-nitrosative ...... diomyopathy and heart failure.

@nl

prefLabel

Role of oxidative-nitrosative ...... diomyopathy and heart failure.

@en

Role of oxidative-nitrosative ...... diomyopathy and heart failure.

@nl

P1433

Q55663138-58770E55-166A-4305-9A61-3A2D53CBF768

P1476

Q55663138-67902DFE-A1FA-4C85-A5FA-385FB270FBD1

P2093

Q55663138-45E36727-E5FA-43E0-BB1F-177557FAFABC

Q55663138-4CFFE925-73E6-48D4-A72D-3D386CDC4158

Q55663138-58C69876-DC79-4647-8B6B-0D6E2D7A2467

Q55663138-79CE3EF2-6DEC-46B7-ADB2-C3F46A40EB8F

P2860

Q55663138-032B5F27-C43B-4392-B40D-5192DCC95765

Q55663138-04E046F3-A231-4268-9131-CA775C6EA308

Q55663138-0597E5D8-2466-4F19-9E97-344B12789EE6

Q55663138-05F2A8BF-C2A5-4494-81C4-A579DCF39FA9

Q55663138-09192D58-7F8D-42C8-9EC6-1D3D3B6191ED

Q55663138-09D37DDD-0054-4B6C-B24D-5F7A3F33F8CA

Q55663138-0EB9E5C9-DD07-48D3-AFED-5F7B602F8675

Q55663138-1434B54D-53FC-45C2-8D28-97C9EEFC10C5

Q55663138-148B6226-3774-4CF5-8C0F-35826601567F

Q55663138-165F6AB3-ABB8-408E-ADA5-C824EA821E57

P304

Q55663138-5B044D31-8082-4F51-97E2-B1D635C7E176

P31

Q55663138-5716C3DD-0DCF-4F9C-88F8-9583F47923E2

P356

Q55663138-3A2272F0-5611-4FAD-BFB2-74D117B8F5E8

P433

Q55663138-EFA75702-1C16-4044-A7F9-54E20FE66BF3

P478

Q55663138-BF0EC8E1-CC04-45DA-9F10-6D43539D7313

P50

Q55663138-B87132E6-5144-4728-A8FB-6B05A706531B

P577

Q55663138-C56CD704-2CBE-4226-935C-6D3C26A57F75

P5875

Q55663138-10A1E8BD-5AB1-4095-B75D-B367E688A3E1

P698

Q55663138-95454B2B-89A8-4ED6-9B29-1FB4EB0BA7AA

P921

Q55663138-E511517D-9538-4BF5-9D6D-84C588EBA02F

P932

Q55663138-24E298FC-35E2-45D7-81F1-042376B73EC7

P356

1570161054368607

P1433

Current Vascular Pharmacology

P1476

Role of oxidative-nitrosative ...... diomyopathy and heart failure.

@en

P2093

Fabio A Recchia

http://www.w3.org/2001/XMLSchema#string

Sachin A Gupte

http://www.w3.org/2001/XMLSchema#string

Sándor Bátkai

http://www.w3.org/2001/XMLSchema#string

Zoltan Ungvári

http://www.w3.org/2001/XMLSchema#string

P2860

Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies

Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart.

Superoxide radicals in feline intestinal ischemia

A placebo-controlled study examining the effect of allopurinol on heart rate variability and dysrhythmia counts in chronic heart failure

Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly

Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor

Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications.

NO/redox disequilibrium in the failing heart and cardiovascular system.

Allopurinol enhances the contractile response to dobutamine and exercise in dogs with pacing-induced heart failure.

Peroxynitrite induced nitration and inactivation of myofibrillar creatine kinase in experimental heart failure.

P304

221-229

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1570161054368607

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7719192

http://www.w3.org/2001/XMLSchema#string

P698

16026319

http://www.w3.org/2001/XMLSchema#string

P921

P932

2225532

http://www.w3.org/2001/XMLSchema#string